EXTON, Pa., Oct. 29, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) will release its financial results for quarter ended September 30, 2002 after the market closes on Tuesday, October 29, 2002. ViroPharma also will host a conference call to further discuss its financial results at 10:30 a.m. EST on October 30, 2002.
To participate in the call, please dial: (800) 992-7413 domestic, (801) 303-7424 for international. After placing the call, please tell the operator you wish to join the ViroPharma conference call. Additionally, the conference call will be Webcasted at ViroPharma's Web site: www.viropharma.com and go to the investor relations section. If you are unable to participate during the live Webcast, the conference call will be archived at this same address for 30 days.
About ViroPharma Incorporated
ViroPharma Incorporated is committed to the commercialization, development and discovery of antiviral pharmaceuticals. ViroPharma is focused on drug development and discovery activities in viral diseases including hepatitis C and RSV disease. The company is also exploring alternatives regarding the future development of Picovir(r) for the treatment of diseases caused by picornaviruses.